Literature DB >> 16216576

Crystal structure of human Taspase1, a crucial protease regulating the function of MLL.

Javed A Khan1, Ben M Dunn, Liang Tong.   

Abstract

Taspase1 catalyzes the proteolytic processing of the mixed lineage leukemia (MLL) nuclear protein, which is required for maintaining Hox gene expression patterns. Chromosomal translocations of the MLL gene are associated with leukemia in infants. Taspase1, a threonine aspartase, is a member of the type 2 asparaginase family, but is the only protease in this family. We report here the crystal structures of human activated Taspase1 and its proenzyme, as well as the characterization of the effects of mutations in the active site region using a newly developed fluorogenic assay. The structure of Taspase1 has significant differences from other asparaginases, especially near the active site. Mutation of the catalytic nucleophile, Thr234, abolishes autocatalytic processing in cis but does not completely block proteolysis in trans. The structure unexpectedly showed the binding of a chloride ion in the active site, and our kinetic studies confirm that chlorides ions are inhibitors of this enzyme at physiologically relevant concentrations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16216576     DOI: 10.1016/j.str.2005.07.006

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  28 in total

1.  A pharmacologic inhibitor of the protease Taspase1 effectively inhibits breast and brain tumor growth.

Authors:  David Y Chen; Yishan Lee; Brian A Van Tine; Adam C Searleman; Todd D Westergard; Han Liu; Ho-Chou Tu; Shugaku Takeda; Yiyu Dong; David R Piwnica-Worms; Kyoung J Oh; Stanley J Korsmeyer; Ann Hermone; Richard Gussio; Robert H Shoemaker; Emily H-Y Cheng; James J-D Hsieh
Journal:  Cancer Res       Date:  2011-12-13       Impact factor: 12.701

2.  Insights into cis-autoproteolysis reveal a reactive state formed through conformational rearrangement.

Authors:  Andrew R Buller; Michael F Freeman; Nathan T Wright; Joel F Schildbach; Craig A Townsend
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

3.  Taspase1-dependent TFIIA cleavage coordinates head morphogenesis by limiting Cdkn2a locus transcription.

Authors:  Shugaku Takeda; Satoru Sasagawa; Toshinao Oyama; Adam C Searleman; Todd D Westergard; Emily H Cheng; James J Hsieh
Journal:  J Clin Invest       Date:  2015-02-09       Impact factor: 14.808

4.  Cleavage of TFIIA by Taspase1 activates TRF2-specified mammalian male germ cell programs.

Authors:  Toshinao Oyama; Satoru Sasagawa; Shugaku Takeda; Rex A Hess; Paul M Lieberman; Emily H Cheng; James J Hsieh
Journal:  Dev Cell       Date:  2013-10-28       Impact factor: 12.270

5.  The N-terminal nucleophile serine of cephalosporin acylase executes the second autoproteolytic cleavage and acylpeptide hydrolysis.

Authors:  Jun Yin; Zixin Deng; Guoping Zhao; Xi Huang
Journal:  J Biol Chem       Date:  2011-05-16       Impact factor: 5.157

6.  Role of asparaginase variable loop at the carboxyl terminal of the alpha subunit in the determination of substrate preference in plants.

Authors:  Michelle Gabriel; Patrick G Telmer; Frédéric Marsolais
Journal:  Planta       Date:  2011-11-30       Impact factor: 4.116

7.  Proteolysis of MLL family proteins is essential for taspase1-orchestrated cell cycle progression.

Authors:  Shugaku Takeda; David Y Chen; Todd D Westergard; Jill K Fisher; Jeffrey A Rubens; Satoru Sasagawa; Jason T Kan; Stanley J Korsmeyer; Emily H-Y Cheng; James J-D Hsieh
Journal:  Genes Dev       Date:  2006-09-01       Impact factor: 11.361

8.  Cell-based analysis of structure-function activity of threonine aspartase 1.

Authors:  Carolin Bier; Shirley K Knauer; Alexander Klapthor; Andrea Schweitzer; Alexander Rekik; Oliver H Krämer; Rolf Marschalek; Roland H Stauber
Journal:  J Biol Chem       Date:  2010-11-17       Impact factor: 5.157

Review 9.  Taspase1: a 'misunderstood' protease with translational cancer relevance.

Authors:  D Wünsch; A Hahlbrock; S Jung; T Schirmeister; J van den Boom; O Schilling; S K Knauer; R H Stauber
Journal:  Oncogene       Date:  2015-12-14       Impact factor: 9.867

10.  Design, syntheses, and evaluation of Taspase1 inhibitors.

Authors:  Jeong Tae Lee; David Y Chen; Zhimou Yang; Alexander D Ramos; James J-D Hsieh; Matthew Bogyo
Journal:  Bioorg Med Chem Lett       Date:  2009-07-10       Impact factor: 2.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.